In July-September 2020, the pharmaceutical company Teva increased sales of the antibiotic with active substance Azithromycin in Ukraine, which accounts for about 11% of its total sales in the country in monetary terms, by 5% compared to the same period in 2019 of the year.
Teva-Ukraine pharmaceutical company told Interfax-Ukraine that since the beginning of the pandemic in Ukraine Teva has sold more than 600,000 packages of this antibiotic.
At the same time, according to the results of the third quarter of 2020, sales in general on the Ukrainian pharmaceutical market in the segment of oral antibiotics in monetary terms grew by 14% compared to the same period in 2019.
Teva-Ukraine said that the company produces both original and generic azithromycin, which is used to treat bacterial respiratory tract infections and other infectious diseases.
Azithromycin is included in the protocol for providing medical care for COVID-19 in Ukraine and in many countries around the world.
“Teva has been providing uninterrupted supplies of azithromycin to Ukraine since the beginning of the pandemic and we will continue doing this,” the company said.
The company said that demand for azithromycin has grown worldwide amid seasonal illnesses and the use of azithromycin for the treatment of co-infections with COVID-19.
“It is possible that certain dosages and forms of production from different manufacturers may be in short supply. In our case, we do not see risks, since Teva’s portfolio contains 17 trade names of azithromycin, most of them are interchangeable. In case of a possible shortage of one of the forms, we proactively warn our partners about this, talk about available alternative forms of production, increase the volume of their imports,” the company said.
At the same time, Teva urges people to remember the rules for using antibiotics and the possible consequences of irrational antibiotic therapy and self-treatment in general.
“Only a doctor can prescribe antibiotics,” the company said.
According to Proxima Research, Azithromycin Teva has been the leader in the oral antibiotics segment in Ukraine since 2019. Over the past month, its share of all medicines in Ukraine amounted to almost 1% in monetary terms.
Teva Ukraine LLC is one of the five largest pharmaceutical companies on the Ukrainian market. The company’s portfolio includes more than 200 generic and original medicines used in most key therapeutic areas.
Teva Ukraine is part of Teva Pharmaceutical Industries Ltd, an international pharmaceutical company headquartered in Israel, founded in 1901. Teva specializes in the development, production and marketing of generic and original medicines and active pharmaceutical ingredients.
The mobile operator Kyivstar has increased 4G coverage in the nine regions of Ukraine, having installed 29 base stations at LTE900 frequencies.
According to the operator’s statement, residents of 176 settlements in Vinnytsia, Dnipropetrovsk, Donetsk, Kirovohrad, Lviv, Mykolaiv, Poltava, Khmelnytsky, and Cherkasy regions got the opportunity to use high-speed mobile Internet.
4G mobile communications became available in the cities of Hirnyk, Ocheretyne, Rodynske, Siversk (Donetsk region), Zhydachiv, Khodoroiv, Busk (Lviv region), Kotelva (Poltava region), Balakhivka, Molodizhne, (Kirovohrad region) and in dozens of villages. More than 160,000 people have the opportunity to use mobile Internet at high speed up to 100 Mbps.
The total number of Kyivstar mobile base stations exceeded 38,000 in October.
Kyivstar has provided access to 4G for almost 85% of the population.
In 2020, the operator invested more than UAH 4 billion in the development of new mobile technologies.
National bank of Ukraine’s official rates as of 30/10/20
Official rates of banking metals from national bank as of October 30
One troy ounce=31.10 grams
DTEK Renewables B.V., which manages DTEK’s renewable energy assets, received UAH 440 million in net profit in the first half of 2020, the company said.
According to the report, with revenue of UAH 4.103 billion, the company’s gross profit amounted to UAH 2.978 billion, operating profit some UAH 2.851 billion.
The mobile network operator Kyivstar has increased its total income by 11.6% in the third quarter of 2020 compared to the same period in 2019, to UAH 6.502 billion, the company’s press service said with reference to its quarterly report on Thursday.
According to the report, in the specified period, Kyivstar increased its earnings before interest, taxes, depreciation and amortization (EBITDA) by 16.9%, to UAH 4.411 billion, thereby increasing EBITDA margin by 3.1 percentage points (pp), to 67.8%.
Revenue from mobile services of the operator in the third quarter amounted to UAH 6.065 billion, which is 11% higher than in the same period in 2019.
Data traffic consumption increased by 50%, to 5.953 GB per subscriber. Consumption of voice services also increased – by 9.7% to 621 minutes per subscriber.
The number of Kyivstar mobile Internet users grew by 3.4%, to 16.8 million, and the total number of active subscribers by the end of the third quarter amounted to 25.8 million, which is 2.2% less than a year earlier.
The operator explained the decrease in the subscriber base relative to the third quarter of 2019 by the partial suspension of the retail network during quarantine.
According to the company, average revenue per user (ARPU) for mobile communications rose by 14.5%, to UAH 78.
“Forced social distancing during the quarantine period influenced the growth in demand for digital solutions. So, in the third quarter of 2020, the number of users of the My Kyivstar self-service system increased by 52% compared to the third quarter of 2019,” the operator said.
Revenues from fixed-line services grew by 19.9%, to UAH 399 million. At the same time, the number of subscribers increased 10%, to 1.1 million ARPU of fixed-line internet increased 9.7%, to UAH 81.
Capital investments for the reporting period amounted to UAH 1.185 billion, which is 13.5% less than in the same period last year.
In general, in January-September 2020, Kyivstar increased its revenue by 11.4%, to UAH 18.641 billion and EBITDA – by 17.6%, to UAH 12.527 billion, while the EBITDA margin increased by 3.6 pp, to 67.9%.
The operator’s capital investments (excluding license costs) for the first nine months of 2020 grew by 22.7%, to UAH 4.299 billion.
